Skip to content

Category: Science

Merck Appoints David Weinreich as New Global Head of R&D and Chief Medical Officer for Healthcare Business Sector

By API User

Not intended for Canada-, UK- or US-based media DARMSTADT, Germany–BUSINESS WIRE– Merck, a leading science and technology company, today announced the appointment of David Weinreich, MD, MBA, as Global Head of R&D and Chief Medical Officer for its Healthcare business sector. Weinreich is a highly-regarded biopharma leader with extensive experience and a proven track record … Continued

How fuel tankers could be key to Australia’s hydrogen export future

By API User

Monash researchers have developed a new membrane technology that extracts hydrogen safely and efficiently from liquid carriers, allowing hydrogen to be transported in regular fuel trucks and pipelines. The innovation tackles the major challenge of hydrogen’s bulky and costly transport by using liquid organic hydrogen carriers (LOHCs), making shipping and storage much easier and cheaper. … Continued

First Nations STEM stars head to UK and NASA [photos and vision available]

By API User

Eight Indigenous Australian university students have been selected for a once-in-a-lifetime opportunity at two of the world’s leading space and science research centres as part of Monash University’s National Indigenous Space Academy (NISA), supported by the Australian Space Agency and CSIRO.   Coming from across Australia, the students will head to NASA’s Jet Propulsion Laboratory … Continued

New Monash study shows seaweed on sandy coastlines contribute to greenhouse gas emissions

By API User

Key points  Monash scientists have discovered sandy coastlines are a previously overlooked contributor of greenhouse gas methane Two new methane-producing microbes discovered at field sites across Port Phillip Bay and Westernport Bay in Victoria, and in Denmark The discovery challenges assumptions about how much carbon coastal vegetation can store  A team of researchers from Monash … Continued

Novotech Supports Groundbreaking Approval of Anlotinib Combination Therapy for Advanced Soft Tissue Sarcoma

By API User

SYDNEY–BUSINESS WIRE– Novotech, a globally recognized full-service clinical research organization (CRO), is proud to have partnered with Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CTTQ Pharma) in achieving a significant regulatory milestone: the approval of Anlotinib Hydrochloride Capsules for a new indication as a first-line treatment for unresectable locally advanced or metastatic soft tissue sarcoma … Continued

Signs of improving seasonal conditions see Victoria’s farm sector confidence edge higher

By API User

Despite ongoing seasonal challenges, Victorian farm sector confidence has edged higher on the back of some winter rainfall, the latest Rabobank Rural Confidence Survey has found.   This consolidates gains in rural sentiment seen earlier in the year.   Across the board, Victoria’s farmers called out the improving seasonal conditions and rising commodity prices as … Continued

3D printing marine habitats for Sydney Harbour species

By API User

Key Facts: There is also a YouTube video outlining the project. https://www.youtube.com/watch?v=kYNu1MzH0Ao A UNSW Sydney project customising artificial seawalls aims to restore oyster populations in Blackwattle Bay. A team of computational designers from the School of Built Environment at UNSW Arts, Design & Architecture has developed innovative 3D-printed reef structures – called BioShelters – to … Continued

UNSW SMaRT Centre study reveals extent of microplastics pollution in Australia

By API User

Key Facts: Microplastic pollution is an emerging environmental contaminant across the globe, with estimates that around three million tonnes of microplastics enter the Earth’s environment each year which will take 50–600 years to completely degrade. Primary microplastics are synthetically manufactured to produce pharmaceuticals, personal care items, plastic goods and textiles. Secondary microplastics are generated due to … Continued

SMSbiotech Initiates Groundbreaking Phase 1 Human Clinical Trial for COPD

By API User

MELBOURNE, Australia–BUSINESS WIRE– SMSbiotech, a San Diego–based leader in regenerative medicine, today announced the initiation of its first-in-human Phase 1 clinical trial for Chronic Obstructive Pulmonary Disease (COPD). This milestone marks the transition of years of dedicated research into clinical development, with the goal of delivering a transformative therapy for millions living with this debilitating … Continued